News pages
2004  
June
July
August
September
October
November
December
2005    
January
February
March
April
May
June

Recent reports in Science and Medicine for December 2004

Some of these links are very transient and may expire within days of posting. Some may require prior registration. Check-in and view frequently to avoid missing great news items. I welcome any suggested articles. (email link). "§" indicates a recommended article.



Holiday Break - Posting will resume 3 January 2005
 

 December 21                  
  1. FDA News:
    • §  FDA Statement on Celebrex (celecoxib). Halting of a Clinical Trial of the Cox-2 Inhibitor [Medscape]
    • §  FDA Statement on Naproxen
    • MedWatch: Bextra (valdecoxib) New information on side effects associated with the use of Bextra, a "boxed" warning, strengthening previous warnings about the risk of life-threatening skin reactions, and a new bolded warning contraindicating the use of Bextra in patients undergoing coronary artery bypass graft (CABG) surgery were added to the label.
    • FDA Statement on Iressa (gefitinib). A large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival benefit from taking Iressa
    • FDA Talk Paper: New Warning for Strattera (atomoxetine). Labeling is being updated with a bolded warning about the potential for severe liver injury following two reports (a teenager and an adult) in patients who had been treated with Strattera for several months, both of whom recovered.
    • FDA Talk Paper: Approval of Vision Blue (trypan blue ophthalmic solution) for staining the anterior lens capsule during cataract surgery.
    • FDA Talk Paper: Approval of biotechnology drug Kepivance (palifermin) to treat mucositis associated with cancer treatments.
    • FDA Approval of Macugen (pegaptanib sodium injection) for age-related macular degeneration
    • FDA Statement on Celebrex DTC Promotion
  2. NIH halts use of COX-2 inhibitor in large cancer prevention trial. [Eurekalert report]
  3. MMWR December 17, 2004 / Vol. 53 / No. 49
    • Estimated Influenza Vaccination Coverage Among Adults and Children --- United States, September 1--November 30, 2004
    • Experiences with Obtaining Influenza Vaccination Among Persons in Priority Groups During a Vaccine Shortage --- United States, October--November, 2004
    • Experiences with Influenza-Like Illness and Attitudes Regarding Influenza Prevention --- United States, 2003--04 Influenza Season
  4. Early online publication: Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet Volume 364, Number 9452 18 December 2004
  5. Syncope Evaluation in the Emergency Department Study (SEEDS) A Multidisciplinary Approach to Syncope Management  Circulation. 2004;110:3636-3645. Published online. (Editorial: Specialized Syncope Evaluation)
  6. Decision-Making About Tamoxifen in Women at High Risk for Breast Cancer: Clinical and Psychological Factors. JCO published online December 14, 2004. [Medscape Many Women at High Risk of Breast Cancer Decline Tamoxifen]
  7. Biennial Versus Annual Mammography and the Risk of Late-Stage Breast Cancer. J Natl Cancer Inst 2004; 96: 1832-1839. [Medscape]
  8. Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study . Journal of Pediatrics December 2004 • Volume 145 • Number 6 [Medscape: Thalidomide Safe, Effective for Severe Systemic Onset Juvenile Rheumatoid Arthritis]
  9. Depressive Symptoms, Insulin Resistance, and Risk of Diabetes in Women at Midlife. Diabetes Care 2004 27: 2856-2862. [Medscape]
 December 20                  
  1. §  EARLY RELEASE: Cardiovascular Toxicity of Valdecoxib. Published at www.nejm.org on December 17, 2004. It will appear in the December 23 NEJM issue.
  2. Sarcoidosis: In Search of the Cause. Am. J. Respir. Crit. Care Med. 2004; 170: 1268-1269
  3. A Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors. Am. J. Respir. Crit. Care Med. 2004; 170: 1324-1330.
  4. Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II. Am. J. Respir. Crit. Care Med. 2004; 170: 1302-1309.
  5. Triggering risk factors for ischemic stroke: A case-crossover study. Neurology 2004 63: 2006-2010.
  6. New England Journal of Medicine Volume 351 December 16, 2004 Number 25
December 17                    

Weekend Reading - Basic Science and general interest articles

  1. FDA Talk Paper: Bextra label updated with boxed warning concerning severe skin reactions and warning regarding cardiovascular risk
  2. FDA Approvals: Omega-3 Acid Ethyl Esters (Omacor) reduces high triglyceride levels; 1% Sodium Hyaluronate (Nuflexxa) for osteoarthritic knee pain; Oxycodone/Ibuprofen 5 mg/400 mg (Combunox) for acute short-term pain; IV administration approved for Treprostinil (Remodulin); Once-Daily Mesalamine Suppository (Canasa 1 g) for ulcerative proctitis. [Medscape report]
  3. §  Obituaries:: November 25, 2004 Sir John Vane, Ingenious and perceptive pharmacologist who won the Nobel Prize for Medicine after discovering how aspirin worked.
  4. §  WHO Statement: Estimating the impact of the next influenza pandemic: enhancing preparedness.
  5. §  A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis. Science 2004 online 10.1126/science.1106753 [Eurekalert: New TB Drug Promises Shorter Treatment][news report]
  6. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nature Medicine, published online: 12 December 2004; | doi:10.1038/nm1162.[Eurekalert report: Nature Medicine: researchers discover key protein in psoriasis]
  7. Trials Support Replacing Tamoxifen With Anastrozole at Two Years. Medscape report from 27th annual San Antonio Breast Cancer Symposium.
  8. Trichuris suis therapy in Crohn’s disease. Gut 2005; 54: 87-90.
  9. Why a Pug is Not a Collie. Science now Dec 15 2004report from PNAS: Molecular origins of rapid and continuous morphological evolution. PNAS published December 13, 2004, 10.1073/pnas.0408118101
  10. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. PNAS published December 16, 2004 . [Science now report]
  11. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF--induced suppressor of human gastrointestinal cancers. PNAS online before print December 1, 2004, 10.1073/pnas.0406142101.
 December 16                  
  1. Report: Loss-of-Function Mutation in Tryptophan Hydroxylase-2 Identified in Unipolar Major Depression. Neuron. Published online Dec. 9, 2004 [Eurekalert: Genetic defect confers risk of major depression, resistance to SSRI drug therapy]
  2. Gene Vaccination to Bias the Immune Response to Amyloid- Peptide as Therapy for Alzheimer Disease. Arch Neurol. 2004;61:1859-1864. [Eurekalert]
  3. §  BMJ Online First: Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ, doi:10.1136/bmj.38302.504063.8F (published 13 Dec 2004) [Medscape and Eurekalert]
  4. JAMA Vol. 292 No. 23, pp. 2809-2936, December 15, 2004
  5. Archives of Internal Medicine Vol. 164 No. 22, Dec 13/27, 2004
 December 15                  
  1. §  Recommendations for the Selective Use of Herpes Simplex Virus Type 2 Serological Tests. Clinical Infectious Diseases online 2005;40:000 [IDSA statement]
  2. Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance. Arterioscler Thromb Vasc Biol 2004 24: 1980 - 1987.
  3. Effects of Anorexia Nervosa on Clinical, Hematologic, Biochemical, and Bone Density Parameters in Community-Dwelling Adolescent Girls. Pediatrics 2004; 114: 1574-1583.[Medscape: Anorexia Nervosa Consequences Demand Vigilant Clinical Monitoring]
  4. MMWR December 10, 2004 / 53(48);Fall-Related Injuries During the Holiday Season --- United States, 2000--2003. 1127-1129.
  5. MMWR December 10, 2004 : Treating Opportunistic Infections Among HIV-Exposed and Infected Children Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. 53(RR14);1-63
  6. Lancet Volume 364, Number 9451     11 December 2004
    • Editorial: HRT: what are women (and their doctors) to do?  [Full Text]
    • Landmines and their victims remain priorities  [Full Text] 
    • §  Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project). [Full Text
    • A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis  [Summary]
    • §  Clinical features of dominant and recessive interferon receptor 1 deficiencies  [Summary
    • A functional autoantibody in narcolepsy  [Summary
    • Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency  [Summary
    • Seminar: The eye in systemic inflammatory diseases  [Summary
 December 14                  
  1. Chronic stress accelerates ultraviolet-induced cutaneous carcinogenesis. J Am Acad Dermatology 2004; 51.[JH news report]
  2. §  New Pertussis Vaccination Strategies beyond Infancy: Recommendations by the Global Pertussis Initiative. Clin Infect Dis 2004;39:1802-1809.
  3. New England Journal of Medicine Volume 351 December 9, 2004 Number 24
  4. BMJ 11 December 2004 (Vol 329, No 7479)
 December 13                  
  1. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. J. D. Browning, and Others. Hepatology 2004;40:1387-1395. [Eurekalert]
  2. JAMA  Vol. 292 No. 22, pp. 2691-E3, December 8, 2004
  3. §  Bone mineral acquisition in adolescents with type 1 diabetes. J Pediatr 145 (5) 662-669
  4. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia.   J Am Coll Cardiology 2004; 44: 2137-2141 (via CardioSource) [WebMD report]
  5. Am J Med 15 November 2004 (Vol. 117, Issue 10)  [limited access]
    • Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. (pages 719-725)
    • § Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. (pages 726-731)
    • Antidepressants and risk of first-time hospitalization for myocardial infarction: A population-based case-control study. (pages 732-737)
    • § Association of body weight with condition-specific quality of life in male veterans. (pages 738-746)
    • § Clinician awareness of adherence to hypertension guidelines. (pages 747-754)
    • Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. (pages 755-761)
    • Reviews: Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: A meta-analysis. (pages 762-774)
    • Review: sEffects of statins on vascular structure and function: A systematic review. (pages 775-790)
    • Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus. (pages 791-795)
    • Editorials: Reducing PSAnxiety: The importance of noninvasive chronic disease management in prostate cancer detection and treatment . (pages 796-798)
    • Editorials: Community-acquired pneumonia guidelines: Peering back through the looking glass…clearly? (pages 799-800)
  6. §  Depression Among Surviving Caregivers: Does Length of Hospice Enrollment Matter? Am J Psychiatry 2004 161: 2257-2262.[Eurekalert]
December 10                    

Weekend Reading - Basic Science and general interest articles

  1. FDA Safety Labeling Changes: (Medscape review) Epivir and Combivir, (Discontinuation of Lamivudine in Epivir, Epivir-HBV, and Combivir associated with HBV exacerbation in HIV/HBV coinfection); Advair Diskus (Salmeterol Xinafoate in Advair Diskus linked to risk of asthma-related deaths), Levofloxacin (Levaquin) and Ofloxacin (Floxin) associated with peripheral neuropathy, tendon effects; Infant's Ibuprofen Suspension (Infant's Advil) May Cause Stomach Bleeding at High Doses,
  2. FDA Medwatch: Procrit (epoetin alfa) important labeling changes to recommended hemoglobin rate of rise and target target hemoglobin in patients with cancer should not exceed 12 grams per deciliter in men and women.
  3. §  Researchers trace how virus that causes AIDS spreads following oral exposure. Eurekalert from the journal AIDS.[limited access]
  4. JCI  | December 1 2004, Volume 114, Issue 11  
  5. Inhaling to mitigate exhaled bioaerosols. PNAS published December 6, 2004, 10.1073/pnas.0408159101 [Eurekalert]
  6. Heart responds to fasting by remodeling vital energy-producing components. [Eurekalert upcoming issue of the journal Biochemistry}
  7. Multidrug-Resistant Bacteria Found to be Airborne in Concentrated Swine Operation. [Eurekalert report from the online edition of Environmental Health Perspectives.]
  8. Human multiple myeloma cells express peroxisome proliferator-activated receptor and undergo apoptosis upon exposure to PPAR ligands. Clinical Immunology 2004; 113: 203-21.(via Science Direct) [Eurekalert news report Research shows existing diabetes drugs may kill multiple myeloma]
  9. Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) comparing blood-pressure lowering treatments has been stopped early due to the significantly better performance of one of the treatments in the trial. [Eurekalert and BBC news reports]
  10. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 97: 1637-1642, 2004. [Science Daily]
  11. Dogs with severe back injuries respond to a new method for treating spinal cord trauma. [Science now report from December issue of the Journal of Neurotrauma.]
 December 9                  
  1. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. J. D. Browning, and Others. Hepatology 2004;40:1387-1395. [Eurekalert]
  2. JAMA  Vol. 292 No. 22, pp. 2691-E3, December 8, 2004
  3. §  Bone mineral acquisition in adolescents with type 1 diabetes. J Pediatr 145 (5) 662-669
  4. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia.   J Am Coll Cardiology, Dec. 7, 2004; vol 44: pp 2137-2141 (via CardioSource) [WebMD report]
  5. Am J Med 15 November 2004 (Vol. 117, Issue 10)  [limited access]
    • Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. (pages 719-725)
    • § Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. (pages 726-731)
    • Antidepressants and risk of first-time hospitalization for myocardial infarction: A population-based case-control study. (pages 732-737)
    • § Association of body weight with condition-specific quality of life in male veterans. (pages 738-746)
    • § Clinician awareness of adherence to hypertension guidelines. (pages 747-754)
    • Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. (pages 755-761)
    • Reviews: Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: A meta-analysis. (pages 762-774)
    • Review: sEffects of statins on vascular structure and function: A systematic review. (pages 775-790)
    • Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus. (pages 791-795)
    • Editorials: Reducing PSAnxiety: The importance of noninvasive chronic disease management in prostate cancer detection and treatment . (pages 796-798)
    • Editorials: Community-acquired pneumonia guidelines: Peering back through the looking glass…clearly? (pages 799-800)
 December 8                  
  1. The Effect of Body Weight on Progression of Knee Osteoarthritis Is Dependent on Alignment. Arthritis & Rheumatism 2004; 50: 3904-3909. [Eurekalert]
  2. Annals of Internal Medicine 7 December 2004 Volume 141 Issue 11
    • §  Early Release: Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction. Kimmel, and Others.
    • Early Release: Cardiovascular Risks of Cyclooxygenase-2 Inhibitors: Where We Stand Now. Finckh and Aronson
    • Early Release: Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Miller, and Others.
    • Vitamin E Supplements: Good in Theory, but Is the Theory Good? Greenberg
    • Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits. Eckart, and Others
    • Management of Implantable Cardioverter Defibrillators in End-of-Life Care. Goldstein, and Others
    • Negative D-dimer Result To Exclude Recurrent Deep Venous Thrombosis: A Management Trial. Rathbun, and Others.
    • §  Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite. Spiegel, and Others [Eurekalert news]
    • IMPROVING PATIENT CARE: Systematic Review: Effects of Resident Work Hours on Patient Safety. Fletcher, and Others.
    • UPDATES Update in Infectious Diseases. Lorber
    • Systematic Review: Transient Left Ventricular Apical Ballooning: A Syndrome That Mimics ST-Segment Elevation Myocardial Infarction . Bybee, and Others.
    • Meta-Analysis: Outcomes in Patients with Suspected Pulmonary Embolism Managed with Computed Tomographic Pulmonary Angiography. Moores, and Others.
    • EDITORIALS: Sudden Cardiac Death in Young Military Recruits: Guarding the Heart of a Soldier. Balady
    • §  A Good Night's Sleep: Future Antidote to the Obesity Epidemic? Flier and Elmquist
    • ON BEING A DOCTOR: A Rose for Dr. Martin. Schott
  3. Researchers Trace How Virus That Causes AIDS Spreads Following Oral Exposure. [Science Daily review from the journal AIDS (limited online access).]
 December 7                  
  1. Strategies for Detecting Adverse Drug Events among Older Persons in the Ambulatory Setting. J Am Med Inform Assoc 2004; 11: 492-498
  2. The Lancet Volume 364, Number 9450     04 December
    • §  Risk of cardiovascular events and rofecoxib: cumulative meta-analysis  [Full Text]
    • Monetary incentives in primary health care and effects on use and coverage of preventive health care interventions in rural Honduras: cluster randomised trial  [Full Text
    • Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow-up of a randomised controlled trial  [Summary]
    • Seminar: The eye in neurological disease  [Summary]
    • Microscopic colitis: a missed diagnosis?  [Summary]
    • Mental health in complex emergencies  [Full Text]
  3. BMJ 4 December 2004 (Vol 329, No 7478)
    • Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso. BMJ  2004;329:1309.
    • Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ  2004;329:1312.
    • Surgical management of inguinal hernia: retrospective cohort study in southeastern Scotland, 1985-2001. BMJ  2004;329:1315-1316.
    • DRUG POINTS: Sibutramine may be associated with memory impairment. BMJ  2004;329:1316.
    • §  Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ  2004;329:1317.
    • Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department. BMJ  2004;329:1321.
    • Clinical review: Tibialis posterior dysfunction: a common and treatable cause of adult acquired flatfoot . BMJ  2004;329:1328-1333
    • Lesson of the week: Clomipramine induced neuroleptic malignant syndrome and pyrexia of unknown origin. BMJ  2004;329:1333-1335
    • Education and debate: Democratisation of scientific advice. BMJ  2004;329:1339-1341
 December 6                  
  1. §  The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure.J Neurol Neurosurg Psychiatry 2004; 75: 1737-1741. [Eurekalert]
  2. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J. Clin. Invest. 2004 114: 1550-1563. [Eurekalert]
  3. §  Synaptic Targeting by Alzheimer's-Related Amyloid Oligomers. J. Neurosci. 2004 24: 10191-10200. [Eurekalert]
  4. Including Walnuts in a Low-Fat/Modified-Fat Diet Improves HDL Cholesterol-to-Total Cholesterol Ratios in Patients With Type 2 Diabetes. Diabetes Care 2004 27: 2777-2783. [Medscape]
  5. Functional Recovery in a Primate Model of Parkinson's Disease following Motor Cortex Stimulation. Neuron, Vol 44, 769-778, 2 December 2004
  6. New England Journal of Medicine Volume 351 December 2, 2004 Number 23
December 3                    

Weekend Reading - Basic Science and general interest articles

  1. FDA News:
    • FDA Talk Paper: FDA Announces Enhancement to Isotretinoin Risk Management Program
    • FDA News: Monoclonal Antibody (Natalizumab) Treatment For Multiple Sclerosis Approved
    • FDA News: FDA Acts to Remove Ephedra-Containing Dietary Supplements From Market
    • MedWatch: Bicillin C-R (penicillin G benzathine and penicillin G procaine injectable suspension) inappropriate use of Bicillin C-R to treat patients infected with syphilis. Bicillin L-A is the only currently approved penicillin G benzathine product indicated for the treatment of syphilis. BLACK BOX WARNING: these products should only be administered by deep intramuscular injection.. [Medscape alert]
    • FDA Talk Paper: FDA Strengthens Labels of Two Specific Types of Antibiotics to Ensure Proper Use
    • FDA Safety Labeling Changes: [Medscape report]
      • NegGram (nalidixic acid) linked to peripheral neuropathy and tendon effects: contraindicated in patients taking melphalan, having porphyria, or history of convulsive disorders
      • Nitrolingual Pumpspray (nitroglycerin lingual spray) interacts with phosphodiesterase inhibitors
      • Serevent (salmeterol) linked to risk of asthma-related death
    • FDA Approvals: [Medscape report]
      • Tysabri: (Natalizumab) for the reduction of relapse frequency in multiple sclerosis
      • Nexium (Esomeprazole) for the reduction of gastric ulcers linked with NSAID use
      • CR002 (Orphan Drug Status) may slow progression of IgA nephropathy
      • Sotradecol (Sodium Tetradecyl Sulfate Injection) for Varicose Veins
  2. Some people are 'immune' to exercise.Exclusive from New Scientist.10:45 02 December 04
  3. Zapped human eggs divide without sperm. Exclusive from New Scientist 19:00 01 December 04
  4. A 24-year follow-up of body mass index and cerebral atrophy. Neurology 2004 63: 1876-1881. (NewScientist: Obesity linked to dementia in women )
  5. Obese Americans Overwhelm Diagnostic Devices [Medscape report from Radiological Society of North America Meeting]

 

 December 2                  
  1. Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group. Blood 2004 104: 2667-2674.[Medscape review]
  2. JAMA. Vol. 292 No. 21, pp. 2547-2684, December 1, 2004.
    • §  Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs. JAMA. 2004;292:2585-2590.
    • Thyroid Status, Disability and Cognitive Function, and Survival in Old Age. JAMA. 2004;292:2591-2599.
    • Thyroid Neoplasia, Autoimmune Thyroiditis, and Hypothyroidism in Persons Exposed to Iodine 131 From the Hanford Nuclear Site. JAMA. 2004;292:2600-2613.
    • Etiology of Pruritic Papular Eruption With HIV Infection in Uganda. JAMA. 2004;292:2614-2621.
    • §  Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis. JAMA. 2004;292:2622-2631.
    • Clinical Crossroads: A 64-Year-Old Woman With a Thyroid Nodule. JAMA. 2004;292:2632-2642.
    • Commentaries: Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: A Counterpoint. JAMA. 2004;292:2643-2646.
    • Editorials: Postmarketing Surveillance—Lack of Vigilance, Lack of Trust. JAMA. 2004;292:2647-2650.
    • Thyroid Disease in the Oldest Old: The Exception to the Rule. JAMA. 2004;292:2651-2654.
    • Controversies : Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis". JAMA. 2004;292:2655-2657.
    • Authors’ Reply to Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"
      JAMA. 2004;292:2658-2659.
  3. Archives of Internal Medicine Vol. 164 No. 21, pp. 2299-2392, November 22, 2004
 December 1                  
  1. Neuropsychological Outcome After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Results From the Stent or Surgery (SoS) Trial. Circulation 2004 110: 3411 - 3417. [Editorial]
  2. One-Year Coronary Bypass Graft Patency: A Randomized Comparison Between Off-Pump and On-Pump Surgery Angiographic Results of the PRAGUE-4 Trial. Circulation 2004 110: 3418 - 3423
  3. §  Cochrane Corner: Stroke Volume 35, Issue 12; December, 2004
  4. Hypertension Grand Rounds: Management of Hypertension in the Very Elderly Patient. Hypertension 2004 44: 800-804.
  5. Immediate Computed Tomography Scanning of Acute Stroke Is Cost-Effective and Improves Quality of Life. Stroke. 2004;35:2477.
  6. Chest Pain Warrants Closer Scrutiny in Some Patients. December issue of the Annals of Emergency Medicine. Ann Emerg Med 2004.
  7. Lancet Volume 364, Number 9449     27 November 2004
    • Early online publications: The whole truth and nothing but the truth? The research that Philip Morris did not want you to see [Summary]
      • Risk of cardiovascular events and rofecoxib: cumulative meta-analysis [Summary]
      • Vioxx, the implosion of Merck, and aftershocks at the FDA[Summary]
    • Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial  [Summary]
    • Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial  [Summary]
    • Multicentre Ibuprofen Prophylaxis Study (MIPS) Investigators* Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda. [Full Text] 
    • Seminar: Insomnia  [Summary
    • Communicable diseases in complex emergencies: impact and challenges  [Full Text
    • Public Health: Human resources for health: overcoming the crisis  [Full Text]
    • Uses of Error: As a doctor you believe in facts, but as a manager you must believe in perceptions  [Summary]